Influenza continues to threaten public health because of its high morbidity and mortality rates, despite the efforts and success on antiviral research. Vaccines and antiviral agents are essential for mitigating the influence of the influenza virus. Due to the frequent antigenic variation of the influenza virus, anti-influenza agents seem to be effective at preventing the infection and treating the epidemic. Here, BOC Sciences provides some small molecules for these researches.
